Cancer Transcriptome Atlas is the First in a Portfolio of GeoMx Products That Enable Spatial Genomics Using the Installed Base of Nearly 20,000 Next Gen Sequencers SEATTLE--(BUSINESS WIRE)-- ...
Premier Access Sites to Offer the Cancer Transcriptome Atlas Service from Labs Across the Globe SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of GeoMx® DSP ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability ...
With over 200 validated antibodies and the option to add custom antibodies, the GeoMx DSP protein portfolio offers options to fit a wide range of spatial profiling application needs. NanoString’s ...
The GeoMx Digital Spatial Profiler measures RNA and protein from tissue regions that a researcher selects, rather than mapping every cell across a slide. That region of interest (ROI) based design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results